scholarly journals Incidence and risk factors for intraocular pressure rise after the scleral buckle surgery for retinal detachment

2021 ◽  
Vol 33 (4) ◽  
pp. 444
Author(s):  
Tarannum Mansoori ◽  
GandrapuPoojitha Mohan ◽  
SatishGooty Agraharam ◽  
Nagalla Balakrishna ◽  
Veerandranath Pesala
Keyword(s):  
Risk Factors ◽  
Intraocular Pressure ◽  
Retinal Detachment ◽  
Pressure Rise ◽  
Scleral Buckle

scholarly journals Sustained Intraocular Pressure Rise after the Treat and Extend Regimen at 3 Years: Aflibercept versus Ranibizumab

2020 ◽  
Vol 2020 ◽  
pp. 1-8
Author(s):  
Alper Bilgic ◽  
Laurent Kodjikian ◽  
Jay Chhablani ◽  
Anand Sudhalkar ◽  
Megha Trivedi ◽  
...  
Keyword(s):  
Risk Factors ◽  
Intraocular Pressure ◽  
Visual Field ◽  
Macular Edema ◽  
Statistical Significance ◽  
Pressure Rise ◽  
Age Related Macular Degeneration ◽  
Secondary Outcome ◽  
Treat And Extend ◽  
Vein Occlusion

Purpose. To determine the risk factors associated with sustained intraocular pressure (IOP) rise in patients enrolled in the treat and extend (T&E) protocol receiving aflibercept/ranibizumab therapy for 3 years. Design. Retrospective, observational chart review. Setting. Multicentric. Patients. 789 patients (1021 eyes; 602 males) enrolled in T&E using aflibercept/ranibizumab for diabetic macular edema (DME), wet age-related macular degeneration (AMD), or macular edema in retinal vein occlusion (RVO). Intervention. The history, examination (clinical and special investigations), and treatment records were thoroughly scrutinized. Sustained IOP rise was defined as a rise in IOP above baseline by ≥6 mmHg and/or >24 mmHg on 2 or more consecutive visits. The Wilk–Shapiro test was used for confirming normality of data. The Mantel–Haenszel test and generalized estimating equations were used to analyse multicentric data as well as to analyse data from both eyes of the same patients in the event that both eyes were under therapy. The relative risk, chi-square test (with and without Yates’ correction), and univariate and multivariate analysis were used wherever appropriate. Statistical significance was set at P<0.05. The primary outcome measure was the determination of risk factors for sustained IOP rise with ranibizumab/aflibercept therapy. Secondary outcome measures included determining the incidence of IOP rise (short term and sustained), visual field, and retinal nerve fibre layer (RNFL) changes. Results. The mean follow-up was 42.4 months. Male gender, South Asian ethnicity, older age, presence of AMD and vein occlusion, use of ranibizumab, higher number of injections, narrow angles, switch to bevacizumab/ranibizumab, and preexisting glaucoma were associated with sustained IOP rise. No significant visual field and RNFL changes were seen. The overall incidence was 8.91%. No patient required filtering surgery. No patient with IOP rise returned to baseline. Conclusion. IOP rise is an important consideration as the chronicity of the condition can eventually lead to glaucomatous changes in eyes with already compromised vision. Follow-ups and use of appropriate therapy can be determined correspondingly.

scholarly journals Risk factors for intraocular pressure rise following phacoemulsification

2013 ◽  
Vol 61 (3) ◽  
pp. 115 ◽  
Author(s):  
Muge Coban-Karatas ◽  
Selcuk Sizmaz ◽  
Rana Altan-Yaycioglu ◽  
Handan Canan ◽  
YoncaAydin Akova
Keyword(s):  
Risk Factors ◽  
Intraocular Pressure ◽  
Pressure Rise

scholarly journals Incidence and risk factors for intraocular pressure rise after transconjunctival vitrectomy

2020 ◽  
Vol 68 (5) ◽  
pp. 812
Author(s):  
Rebecca Varkey ◽  
GopalS Pillai ◽  
UG Unnikrishnan ◽  
Natasha Radhakrishnan
Keyword(s):  
Risk Factors ◽  
Intraocular Pressure ◽  
Pressure Rise ◽  
Transconjunctival Vitrectomy

scholarly journals Lyophilized amniotic membrane patch (LAMPatch) as a replacement of tamponades in the treatment of primary rhegmatogenous retinal detachment

2020 ◽  
Vol 6 (1) ◽  
Author(s):  
Mario Saravia ◽  
Luis Zeman ◽  
Alejandro Berra
Keyword(s):  
Intraocular Pressure ◽  
Retinal Detachment ◽  
Amniotic Membrane ◽  
Case Series ◽  
Pressure Rise ◽  
Human Amniotic Membrane ◽  
Retinal Breaks ◽  
23 Gauge ◽  
Membrane Patch

Abstract Background The basis of retinal detachment repair is sealing the retinal breaks. In order to seal the retinal breaks, chorioretinal adhesion around these lesions has to be achieved. Laser retinopexy is not immediate thus necessitates the use of a temporal endotamponade to maintain both tissues in apposition. We propose the use of a patch of lyophilized human amniotic membrane (LAMPatch) in order to occlude the retinal tear effectively until the chorioretinal adhesion is settled, overcoming the risks and limitations of the current tamponades. Methods 23-gauge vitrectomy was performed on eyes with primary retinal detachment with single retinal breaks of less than one-hour extension. A LAMPatch was deployed over the retinal breaks after retina was repositioned with perfluorocarbon. Neither gas nor silicon oil were injected. Results Six eyes of six patients with total or partial retinal detachment were included. Retinas remained reattached in all cases until the end on follow-up (3, 5 months). Best-corrected visual acuity at 1-week postop was between 20/30 and 20/100. Neither elevations of intraocular pressure, cataracts nor signs of inflammation were registered during follow-up. No second surgeries were needed. Conclusion This technique has proven to be safe and effective in this small case series. No intraocular pressure rise, inflammation or cataracts were registered until last follow-up visit.

Risk Factors For Recurrent Myopic Macular Hole Retinal Detachment After Silicone Oil Removal In Patients With Open Flat Macular Hole

2021 ◽  
Author(s):  
Hamouda Hamdy Ghoraba ◽  
Hosam Othman Mansour ◽  
Mohamed Ahmed Abdelhafez Elsayed ◽  
Adel Galal Zaky ◽  
Mohamed Amin Heikal ◽  
...  
Keyword(s):  
Risk Factors ◽  
Retinal Detachment ◽  
Macular Hole ◽  
Silicone Oil ◽  
Significant Risk ◽  
Minimum Diameter ◽  
Univariate Logistic Regression Analysis ◽  
Macular Hole Retinal Detachment ◽  
Myopic Macular Hole ◽  
Group 2

Purpose: To evaluate the risks that might be associated with recurrent macular hole retinal detachment (Re MHRD) after silicone oil (S.O) removal in myopic patients with open flat macular hole (MH). Methods: In this retrospective series, we assessed the different factors that might be associated with recurrent MHRD after S.O removal in 48 eyes with open flat MH that underwent S.O removal after successful MHRD repair by dividing the enrolled eyes into 2 groups: group 1 included 38 eyes with flat open MH and flat retina after S.O removal and group 2 included 10 eyes with flat open MH and recurrent MHRD after S.O removal. Results: Ten of 48 eyes (20.8%) with open flat MH developed recurrent MHRD after S.O removal. Univariate logistic regression analysis revealed that MH at the apex of PS, MH minimum diameter, hole form factor (HFF) and MH index (MHI) were significant risk factors for recurrent MHRD after S.O removal in myopic patients with open flat MH. Conclusions: If there is a "flat open" MH that is large, located at the apex of PS or with HHF or MHI of less than 0.9-0.5, it has a high chance of recurrent MHRD after S.O removal.

scholarly journals Incidence of elevated intraocular pressure after intravitreal injection in Japanese patients with age-related macular degeneration

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Maiko Maruyama-Inoue ◽  
Tatsuya Inoue ◽  
Shaheeda Mohamed ◽  
Yoko Kitajima ◽  
Shoko Ikeda ◽  
...  
Keyword(s):  
Risk Factors ◽  
Intraocular Pressure ◽  
Macular Degeneration ◽  
Intravitreal Injection ◽  
Odds Ratio ◽  
Japanese Patients ◽  
Age Related Macular Degeneration ◽  
Age Related ◽  
Elevated Intraocular Pressure ◽  
History Of

AbstractThe purpose of this study was to report the incidence of elevated intraocular pressure (IOP) after intravitreal injection (IVI) of anti-vascular endothelial growth factor (VEGF) in Japanese patients with age-related macular degeneration (AMD). A retrospective study of chart review of patients who underwent ≥ 10 intravitreal anti-VEGF injections between April 2009 and December 2019 was conducted. Elevated IOP was defined as IOP ≥ 25 mmHg at one visit. Cases with elevated IOP resulting from IVI were identified. Furthermore, the association between elevated IOP and some parameters, as the risk factors that influence elevated IOP, was investigated. A total of 402 eyes of 370 patients were included in this study. Twenty-eight eyes of 26 patients (7.0%) were identified as cases with elevated IOP after IVI. The mean time of elevation after baseline was 50.6 ± 26.5 months. History of glaucoma (p = 0.021; odds ratio, 5.85), treatment modality (p = 0.019; odds ratio, 6.32), and total number of injections (p = 0.003; odds ratio, 1.03) were significantly associated with elevated IOP. A late complication of elevated IOP is associated with IVI in patients with AMD. Particularly, history of glaucoma and treat and extend regimen with frequent injections were found to be risk factors of elevated IOP.

Sign in / Sign up

Export Citation Format

Share Document